Wall Street Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
993
-224
-18% -$76.7K 0.19% 79
2026
Q1
$428K Buy
+1,217
New +$434K 0.25% 64
2025
Q4
Sell
-990
Closed -$279K 101
2025
Q3
$279K Buy
990
+258
+35% +$74.8K 0.21% 72
2025
Q2
$204K Buy
+732
New +$207K 0.18% 76

Other funds holding AMGN

Wall Street Financial Group's AMGN Position: Q2 2026 in Review

Wall Street Financial Group reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $76.7K and leaving 993 shares worth $360K. The position accounts for 0.19% of the portfolio, ranked #79.

Wall Street Financial Group first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $428K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wall Street Financial Group held 993 shares of Amgen worth $360K as of Q2 2026.
  • Wall Street Financial Group sold 224 Amgen shares in Q2 2026, an estimated $76.7K.
  • Amgen made up 0.19% of Wall Street Financial Group's portfolio in Q2 2026, its #79 holding.
  • Wall Street Financial Group first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • Wall Street Financial Group's Amgen position peaked at $428K in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.